Fulcrum Therapeutics (FULC) Non-cash Items (2018 - 2026)
Fulcrum Therapeutics (FULC) has 9 years of Non-cash Items data on record, last reported at $27.1 million in Q1 2026.
- On a quarterly basis, Non-cash Items rose 483.5% to $27.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $27.1 million, a 483.5% increase, with the full-year FY2025 number at $5.8 million, up 9.14% from a year prior.
- Non-cash Items reached $27.1 million in Q1 2026 per FULC's latest filing, down from $61.4 million in the prior quarter.
- Over the last five years, Non-cash Items for FULC hit a ceiling of $61.4 million in Q4 2025 and a floor of $1.6 million in Q3 2022.
- A 5-year average of $14.6 million and a median of $4.9 million in 2023 define the central range for Non-cash Items.
- Peak YoY movement for Non-cash Items: plummeted 93.04% in 2022, then skyrocketed 1389.18% in 2024.
- Tracing FULC's Non-cash Items over 5 years: stood at $1.9 million in 2022, then skyrocketed by 701.74% to $15.1 million in 2023, then tumbled by 64.58% to $5.4 million in 2024, then skyrocketed by 1046.77% to $61.4 million in 2025, then tumbled by 55.87% to $27.1 million in 2026.
- Business Quant data shows Non-cash Items for FULC at $27.1 million in Q1 2026, $61.4 million in Q4 2025, and $43.3 million in Q3 2025.